In vivo temperature mapping of prostate during treatment with TherMatrx TMx-2000 device: Heat field and MRI determinations of necrotic lesions
Author
dc.contributor.author
Larson, Benjamin
Author
dc.contributor.author
Huidobro, Christian
Author
dc.contributor.author
Acevedo, Cristian
Author
dc.contributor.author
Busel, David
Author
dc.contributor.author
Mynderses, Lance
Author
dc.contributor.author
Collins, Joseph
Author
dc.contributor.author
Larson, Thayne
Admission date
dc.date.accessioned
2019-01-29T17:56:58Z
Available date
dc.date.available
2019-01-29T17:56:58Z
Publication date
dc.date.issued
2005
Cita de ítem
dc.identifier.citation
Journal of Endourology, Volumen 19, Issue 8, 2018, Pages 1021-1025
Identifier
dc.identifier.issn
08927790
Identifier
dc.identifier.other
10.1089/end.2005.19.1021
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/163900
Abstract
dc.description.abstract
Background and Purpose: The effectiveness of any thermotherapy device is determined by the temperatures created and how long they are applied. Understanding the heating characteristics of a thermotherapy device is vital to its correct implementation. Interstitial temperature mapping was used to determine the heat field created within the prostate by the TherMatrx TMx-2000 transurethral microwave thermotherapy (TUMT) device. Gadolinium-enhanced MRI was used to determine the extent, type, and pattern of coagulation necrosis caused by TUMT. Patients and Methods: Interstitial temperature mapping was performed during treatment in five patients with benign prostatic hyperplasia using 24 temperature sensors inserted through the perineum and arrayed throughout the prostate under ultrasound and X-ray guidance. Gadolinium-enhanced MRI scans were performed on all patients 1 week after treatment. Results: Interstitial temperature mapping found the heat field created to peak at the urethral surface